NCT02923466 2022-04-27
Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors
Vyriad, Inc.
Phase 1 Completed
Clinical Trials
6 trialsNCT01337505 2022-02-10
Safety and Maximum Tolerated Dose (MTD) Study of INNO-206 in Subjects With Advanced Solid Tumors
ImmunityBio, Inc.
Phase 1 Completed
NCT01151930 2020-11-17
Long-Term Compassionate Use Study for Continued Administration of SCB01A-01
SynCore Biotechnology Co., Ltd.
No longer available
NCT01435096 2020-03-03
BN80927 in Patients With Advanced Malignant Solid Tumors
Ipsen
Phase 1 Completed
NCT01184807 2014-03-26
Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors
Otsuka Beijing Research Institute
Phase 1 Completed
NCT01951846 2013-09-27
To Determine the Maximum Tolerated Dose (MTD) of BIBF 1120 in Patients With Solid Tumours
Boehringer Ingelheim
Phase 1 Completed